First Block, Onpharma and Crito Capital launch Solana-based STO for U.S. medical device company

First Block, Onpharma Company and Crito Capital LLP said they have launched what they describe as the first Solana-based Security Token Offering (STO) for an established U.S. operating business. The offering is structured under U.S. securities law as a Regulation S offshore issuance for non-U.S. investors. The firms said the deal is intended to bring tokenized equity in a real-world operating company to Solana-based capital formation, according to Chainwire.